ImageneBio (IMA) Enterprise Value (2020 - 2025)

ImageneBio has disclosed Enterprise Value across 6 years of filings, most recently posting -$135.3 million for Q4 2025.

• Enterprise Value for Q4 2025 came in at -$135.3 million, down 318.56% year-over-year; the trailing twelve-month figure through Dec 2025 was -$135.3 million (down 318.56% YoY), and the FY2025 annual result was -$135.3 million, down 318.56% from the prior year.
• Enterprise Value came in at -$135.3 million for Q4 2025 at ImageneBio, up from -$142.6 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $61.9 million in Q4 2024 to a low of -$281.0 million in Q1 2021.
• The 5-year median for Enterprise Value is -$157.3 million (2023), against an average of -$164.7 million.
• Across the five-year window, Enterprise Value plunged 340.21% in 2021 and surged 135.29% in 2024, its largest moves.
• ImageneBio's Enterprise Value stood at -$232.2 million in 2021, then surged by 32.41% to -$156.9 million in 2022, then decreased by 11.8% to -$175.5 million in 2023, then soared by 135.29% to $61.9 million in 2024, then plunged by 318.56% to -$135.3 million in 2025.
• The last three Enterprise Value figures came in at -$135.3 million (Q4 2025), -$142.6 million (Q3 2025), and -$95.6 million (Q2 2025), per Business Quant data.